Amneal Pharmaceuticals Inc
(AMRX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
by (Cboe BZX)
[[ item.lastPrice ]]
[[ item.priceChange ]]
([[ item.percentChange ]])
[[ item.tradeTime ]]
[NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]]
[[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]]
[[ item.lastPriceExt ]]
[[ item.priceChangeExt ]]
([[ item.percentChangeExt ]])
[[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 03-2018 | 12-2017 | 09-2017 | 06-2017 | 03-2017 | |
| Cash Flows From Operating Activities | |||||
| Net Income | 51,652 | 169,325 | 107,131 | 80,009 | -98,431 |
| Depreciation Amortization | 15,921 | 50,521 | 36,989 | 23,599 | 25,751 |
| Income taxes - deferred | -512 | 742 | -534 | 244 | 32,195 |
| Accounts receivable | 10,196 | 43,463 | 49,865 | 31,648 | 43,033 |
| Other Working Capital | -31,119 | -1,048 | 17,668 | 19,944 | 20,692 |
| Other Operating Activity | -19,109 | -28,816 | -42,197 | -60,035 | 16,565 |
| Operating Cash Flow | $27,029 | $234,187 | $168,922 | $95,409 | $39,805 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | -19,499 | -94,771 | -70,153 | -54,612 | -8,679 |
| Net Acquisitions | N/A | 15,717 | N/A | N/A | N/A |
| Sale Of Investment | N/A | N/A | N/A | N/A | 529 |
| Purchase Sale Intangibles | N/A | -19,500 | -19,500 | N/A | N/A |
| Other Investing Activity | 0 | -19,500 | -19,500 | 0 | 0 |
| Investing Cash Flow | $-19,499 | $-98,554 | $-89,653 | $-54,612 | $-8,150 |
| Cash Flows From Financing Activities | |||||
| Debt Issued | N/A | 250,000 | 275,000 | 250,000 | N/A |
| Debt Repayment | -3,606 | -13,899 | -10,260 | -6,623 | -55,000 |
| Common Stock Issued | N/A | N/A | N/A | N/A | 170 |
| Other Financing Activity | -29,640 | -331,116 | -360,251 | -275,114 | -1,266 |
| Financing Cash Flow | $-33,246 | $-95,015 | $-95,511 | $-31,737 | $-56,096 |
| Exchange Rate Effect | 411 | -242 | 50 | 5,238 | 1,560 |
| Beginning Cash Position | 77,922 | 37,546 | 37,546 | 37,546 | 180,133 |
| End Cash Position | 52,617 | 77,922 | 21,354 | 51,844 | 157,252 |
| Net Cash Flow | $-25,305 | $40,376 | $-16,192 | $14,298 | $-22,881 |
| Free Cash Flow | |||||
| Operating Cash Flow | 27,029 | 234,187 | 168,922 | 95,409 | 39,805 |
| Capital Expenditure | -19,499 | -94,771 | -70,153 | -54,612 | -8,679 |
| Free Cash Flow | 7,530 | 139,416 | 98,769 | 40,797 | 31,126 |